BioMarin Pharmaceutical shares owned by New England Research & Management
Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by New England Research & Management
from 13F filings
Historical chart of New England Research & Management investment in BioMarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including BioMarin Pharmaceutical held by New England Research & Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioMarin Pharmaceutical by New England Research & Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $958k | 14k | 70.31 |
| 2024-06-30 | $747k | 9.1k | 82.31 |
| 2024-03-31 | $1.3M | 15k | 87.36 |
| 2023-03-31 | $929k | 9.6k | 97.28 |
| 2022-03-31 | $722k | 9.4k | 77.11 |
| 2021-12-31 | $443k | 5.0k | 88.39 |
| 2020-12-31 | $592k | 6.8k | 87.70 |
| 2019-06-30 | $270k | 3.2k | 85.71 |
| 2019-03-31 | $311k | 3.5k | 88.86 |
| 2018-09-30 | $533k | 5.5k | 96.91 |
More positions owned by New England Research & Management
View all positions for New England Research & Management